| scholarly article | Q13442814 |
| review article | Q7318358 |
| P356 | DOI | 10.1001/JAMA.1992.03480030084043 |
| P698 | PubMed publication ID | 1727966 |
| P2093 | author name string | M H Bornstein | |
| L C Mayes | |||
| B Zuckerman | |||
| R H Granger | |||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 406-408 | |
| P577 | publication date | 1992-01-01 | |
| P1433 | published in | The Journal of the American Medical Association | Q1470970 |
| P1476 | title | The problem of prenatal cocaine exposure. A rush to judgment | |
| P478 | volume | 267 |
| Q48428612 | A mouse model of transplacental cocaine exposure. Clinical implications for exposed infants and children |
| Q34644567 | Adolescents with and without gestational cocaine exposure: Longitudinal analysis of inhibitory control, memory and receptive language. |
| Q51510160 | Animal behavior models. Increased sensitivity to stressors and other environmental experiences after prenatal cocaine exposure. |
| Q36691948 | Attachment Representations and Early Interactions in Drug Addicted Mothers: A Case Study of Four Women with Distinct Adult Attachment Interview Classifications |
| Q41337977 | Background and overview of mental health and substance abuse treatment systems: meeting the needs of women who are pregnant or parenting |
| Q40393369 | Cocaine Babies: A Result of Multiple Teratogenic Influences |
| Q41527898 | Cocaine’s Effects on Neuroendocrine Systems: Clinical and Preclinical Studies |
| Q34538501 | Comparing attitudes about legal sanctions and teratogenic effects for cocaine, alcohol, tobacco and caffeine: a randomized, independent samples design |
| Q50626128 | Executive function in preschool children prenatally exposed to methadone or buprenorphine. |
| Q49010044 | Fetal syndromes and the charter: the Winnipeg glue-sniffing case |
| Q46365063 | Finding common ground: the necessity of an integrated agenda for women's and children's health |
| Q28652508 | Genetic Addiction Risk Score (GARS): molecular neurogenetic evidence for predisposition to Reward Deficiency Syndrome (RDS) |
| Q42289403 | Hypertension and pulmonary oedema associated with ketamine administration in a patient with a history of substance abuse |
| Q71848885 | Implementation of a Family-Centered Treatment Program for Substance-Abusing Women and Their Children: Barriers and Resolutions |
| Q72205116 | Intrauterine cocaine, lead, and nicotine exposure and fetal growth |
| Q51631177 | Is there a cocaine baby syndrome? |
| Q58054484 | Issues of Developmental Measurement in Clinical Research and Practice Settings with Children Who Were Prenatally Exposed to Drugs |
| Q58385160 | Maternal cocaine use: Impact onchild health and development |
| Q41740859 | Moral and social issues regarding pregnant women who use and abuse drugs |
| Q28367327 | Mother-infant interaction at 12 months in prenatally cocaine-exposed children |
| Q51582181 | Neonatal withdrawal syndrome in infants exposed to cocaine and methadone. |
| Q30429194 | Neurodevelopmental effects of cocaine |
| Q44960818 | Neurological and developmental outcomes of prenatally cocaine-exposed offspring from 12 to 36 months |
| Q51561669 | New evidence for neurobehavioral effects of in utero cocaine exposure. |
| Q41929004 | Normal high-resolution cerebral 99mTc-HMPAO SPECT scans in symptomatic neonates exposed to cocaine |
| Q32066785 | Perceptions and attitudes toward prenatal cocaine exposure in young children |
| Q34444382 | Preadolescent behavior problems after prenatal cocaine exposure: Relationship between teacher and caretaker ratings (Maternal Lifestyle Study) |
| Q40718044 | Prenatal cocaine exposure and the development of the human eye. |
| Q51635974 | Prenatal cocaine exposure: nine years later. |
| Q39471205 | Prenatal coke: what's behind the smoke? Prenatal cocaine/alcohol exposure and school-age outcomes: the SCHOO-BE experience |
| Q34170218 | Prenatal drug exposure and social policy: the search for an appropriate response |
| Q44741083 | Prenatal exposure to cocaine decreases adenylyl cyclase activity in embryonic mouse striatum. |
| Q34284169 | Prenatal methamphetamine exposure and neonatal neurobehavioral outcome in the USA and New Zealand. |
| Q36606872 | Prenatal methamphetamine use and neonatal neurobehavioral outcome |
| Q35041135 | Prenatal toxicology screening for substance abuse in research: codes and consequences |
| Q30377895 | Public health and international drug policy. |
| Q38568644 | Relation of maternal cocaine use to the risks of prematurity and low birth weight |
| Q34424558 | Relationship of prenatal cocaine exposure and maternal postpartum psychological distress to child developmental outcome |
| Q33876585 | Risk assessment |
| Q37080736 | Severity of prenatal cocaine exposure and child language functioning through age seven years: a longitudinal latent growth curve analysis |
| Q50511947 | Standardized test performance of children with a history of prenatal exposure to multiple drugs/cocaine. |
| Q52182684 | Substance abuse: infant and childhood outcomes. |
| Q70546511 | The effects of intrauterine cocaine exposure in newborns |
| Q34108600 | The effects of maternal cocaine abuse on mothers and newborns |
| Q46205959 | The interplay of national, state, and local policy in financing care for drug-affected women and children in California |
| Q51146128 | The social matrix of aggression. Enactments and representations of loving and hating in the first years of life. |
| Q41180217 | Toxicology testing in neonates. Is it ethical, and what does it mean? |
| Q48441291 | Transplacental cocaine exposure. 1: A rodent model |
| Q72205076 | Trends in the US prevalence of drug-using parturient women and drug-affected newborns, 1979 through 1990 |
Search more.